Literature DB >> 16516332

Comorbid medical and psychiatric conditions and substance abuse in HCV infected persons on dialysis.

Adeel A Butt1, Robert Evans, Melissa Skanderson, A Obaid Shakil.   

Abstract

BACKGROUND/AIMS: The burden of comorbidity in the Hepatitis C virus (HCV) infected persons on dialysis is unknown.
METHODS: We identified all HCV infected and uninfected subjects in the United States Renal Data System in the years 1997-1998 using ICD-9 codes. Controls were matched on the date of first dialysis. ICD-9 codes and claims data was used to identify medical and psychiatric comorbidities.
RESULTS: We identified 5,737 HCV infected persons and 11,228 HCV uninfected subjects. HCV infected subjects were younger, more likely to be black race and male and more likely to have the following comorbidities: hypertension; hepatitis B; cirrhosis; wasting; anemia; human immunodeficiency virus (HIV) infection; major depression; mild depression; bipolar disorder; schizophrenia; post-traumatic stress disorder; drug use; alcohol use; smoking and less likely to have the following comorbidities: coronary artery disease; stroke; peripheral vascular disease; diabetes; cancer; erythropoietin use. After adjusting for age, gender and race, HCV infected subjects were more likely to have hypertension, hepatitis B, cirrhosis, wasting, anemia and HIV infection and less likely to have coronary artery disease and stroke.
CONCLUSIONS: HCV infected persons on dialysis are more likely to have psychiatric comorbidities and substance abuse, as well as certain medical comorbidities. These factors should be considered when developing future intervention strategies.

Entities:  

Mesh:

Year:  2006        PMID: 16516332     DOI: 10.1016/j.jhep.2006.01.024

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  8 in total

1.  Hepatitis C progressing to hepatocellular carcinoma: the HCV dialysis patient in dilemma.

Authors:  Wendy A Henderson; Ravi Shankar; Jessica M Gill; Kevin H Kim; Marc G Ghany; Melissa Skanderson; Adeel A Butt
Journal:  J Viral Hepat       Date:  2009-06-28       Impact factor: 3.728

2.  Depression and all-cause mortality risk in HIV-infected and HIV-uninfected US veterans: a cohort study.

Authors:  K So-Armah; S K Gupta; S Kundu; J C Stewart; J L Goulet; A A Butt; J J Sico; V C Marconi; S Crystal; M C Rodriguez-Barradas; M Budoff; C L Gibert; C-Ch Chang; R Bedimo; M S Freiberg
Journal:  HIV Med       Date:  2019-03-29       Impact factor: 3.180

3.  Chromium Therapy for Insulin Resistance Associated with HIV-Disease.

Authors:  Seth A Stein; Margaret Mc Nurlan; Brett T Phillips; Catherine Messina; Dennis Mynarcik; Marie Gelato
Journal:  J AIDS Clin Res       Date:  2013-09-07

4.  The association between hepatitis C infection and prevalent cardiovascular disease among HIV-infected individuals.

Authors:  Matthew S Freiberg; Debbie M Cheng; Kevin L Kraemer; Richard Saitz; Lewis H Kuller; Jeffrey H Samet
Journal:  AIDS       Date:  2007-01-11       Impact factor: 4.177

5.  HIV, Hepatitis C, and Abstinence from Alcohol Among Injection and Non-injection Drug Users.

Authors:  Jennifer C Elliott; Deborah S Hasin; Malka Stohl; Don C Des Jarlais
Journal:  AIDS Behav       Date:  2016-03

6.  Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis.

Authors:  Donna L White; Vlad Ratziu; Hashem B El-Serag
Journal:  J Hepatol       Date:  2008-08-21       Impact factor: 25.083

7.  Hepatitis C virus infection as a traumatic experience.

Authors:  Mychelle Morais-de-Jesus; Renato Daltro-Oliveira; Karine Miranda Pettersen; Adriana Dantas-Duarte; Luciana Di-Domizio Amaral; Patrícia Cavalcanti-Ribeiro; Carlos Teles Santos; Maria Isabel Schinoni; Liana R Netto; Lucas Araújo-de-Freitas; Raymundo Paraná; Angela Miranda-Scippa; Karestan C Koenen; Lucas C Quarantini
Journal:  PLoS One       Date:  2014-10-23       Impact factor: 3.240

8.  Interferon-Based Treatment of Hepatitis C Virus Infection Reduces All-Cause Mortality in Patients With End-Stage Renal Disease: An 8-Year Nationwide Cohort Study in Taiwan.

Authors:  Yueh-Han Hsu; Peir-Haur Hung; Chih-Hsin Muo; Wen-Chen Tsai; Chih-Cheng Hsu; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.